MindMed to Participate at May Investor Conferences
09 Maggio 2024 - 10:01PM
Business Wire
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or
“MindMed”), a clinical stage biopharmaceutical company developing
novel product candidates to treat brain health disorders, announced
today that members of the Company’s management team will
participate in the following investor conferences:
- 2024 RBCCM Global Healthcare Conference
- Format: Fireside Chat
- Date and Time: Wednesday, May 15, 2024 at 11:00 am EDT
- Location: New York, NY
- Webcast Link: 2024 RBCCM Global Healthcare Conference
- HCW's 2nd Annual BioConnect Investor Conference
- Format: 1x1 investor meetings only
- Date: May 20, 2024
- Location: New York, NY
An audio webcast and replay of the fireside chat at the 2024
RBCCM Global Healthcare Conference will be accessible on MindMed’s
Investor Relations website for up to 90 days following the
event.
About MindMed
MindMed is a clinical stage biopharmaceutical company developing
novel product candidates to treat brain health disorders. Our
mission is to be the global leader in the development and delivery
of treatments that unlock new opportunities to improve patient
outcomes. We are developing a pipeline of innovative product
candidates, with and without acute perceptual effects, targeting
neurotransmitter pathways that play key roles in brain health
disorders. MindMed trades on NASDAQ under the symbol MNMD.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240509762996/en/
For Media: media@mindmed.co For Investors:
ir@mindmed.co
Grafico Azioni Mind Medicine MindMed (NASDAQ:MNMD)
Storico
Da Feb 2025 a Mar 2025
Grafico Azioni Mind Medicine MindMed (NASDAQ:MNMD)
Storico
Da Mar 2024 a Mar 2025
